Located in Guangzhou, China, Guangzhou Daji Medical Science and Technology Co., Ltd.(hereinafter referred to as “DaJiMed”) is dedicated in R&D, manufacturing, marketing and sales of blood filtration products, mainly on premium disposable leukocyte reduction filters.

With over 20 years' experience on leukocyte filtration, DaJiMed has obtained more than 30 patents. With the goal of enabling a safer supply of blood transfusion products, DaJiMed membrane multi-modification technology has been developed to better remove leukocytes(WBCs) from blood. Our 4th-gen filter's leukocyte reduction rate is able to reach 99.9999%, exceeding current international standards. Its low hemolysis rate, low WBCs residual rate, fast filtration etc., also demonstrate DaJiMed as unique in China and premium in the world.

Providing high-quality and performance products to ensure safety and quality in blood transfusion, DaJiMed's leukocyte reduction filter system has already been globally adopted in Europe, Asia, America, etc.. It clinically helps sufferers get leukocyte-free blood that is usually recommended in blood transfusion in Thalassemia, aplastic anemia, sickle cell anemia, leukemia, transfusion-transmitted infection,organ transplantation, prevention of platelet refractoriness in thrombocytopenia,multiply or chronically transfusion etc.